Olema Pharmaceuticals Inc
NASDAQ:OLMA

Watchlist Manager
Olema Pharmaceuticals Inc Logo
Olema Pharmaceuticals Inc
NASDAQ:OLMA
Watchlist
Price: 26.23 USD -4.44% Market Closed
Market Cap: 2.1B USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of OLMA.

The Intrinsic Value is calculated as the average of DCF and Relative values:

OLMA Intrinsic Value
Not Available
Base Case Scenario
Compare OLMA to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about OLMA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Olema Pharmaceuticals Inc

Current Assets 334.3m
Cash & Short-Term Investments 329m
Receivables 2.1m
Other Current Assets 3.3m
Non-Current Assets 18.1m
PP&E 1.9m
Other Non-Current Assets 16.2m
Current Liabilities 41.7m
Accounts Payable 3.5m
Accrued Liabilities 38.2m
Non-Current Liabilities 3.3m
Long-Term Debt 3m
Other Non-Current Liabilities 310k
Efficiency

Free Cash Flow Analysis
Olema Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Olema Pharmaceuticals Inc

Revenue
0 USD
Operating Expenses
-165.4m USD
Operating Income
-165.4m USD
Other Expenses
15.4m USD
Net Income
-150m USD
Fundamental Scores

OLMA Profitability Score
Profitability Due Diligence

Olema Pharmaceuticals Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
27/100
Profitability
Score

Olema Pharmaceuticals Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

OLMA Solvency Score
Solvency Due Diligence

Olema Pharmaceuticals Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Olema Pharmaceuticals Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

OLMA Price Targets Summary
Olema Pharmaceuticals Inc

Wall Street analysts forecast OLMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OLMA is 46.54 USD with a low forecast of 38.38 USD and a high forecast of 63 USD.

Lowest
Price Target
38.38 USD
46% Upside
Average
Price Target
46.54 USD
77% Upside
Highest
Price Target
63 USD
140% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Olema Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for OLMA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

OLMA Insider Trading
Buy and sell transactions by insiders